These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

3575 related articles for article (PubMed ID: 5679636)

  • 1. [On the possibilities of using labelled 3-(3,4-dioxyphenyl)-alanine (DOPA) in the radioisotope therapy of melanomas].
    Vdovenko VM; Ivanov II; Bobrova VN; Gavrilenko IS; Ivanov AI; Rumjanceva LN; Zarkov AV; Volina VV; Klimko MS
    Radiobiol Radiother (Berl); 1968; 9(1):49-60. PubMed ID: 5679636
    [No Abstract]   [Full Text] [Related]  

  • 2. [A historadiographic study of the incorporation of 3-(3,4-dioxyphenyl)-alanine-2,5,6 3H3 into Harding-Passy melanoma cells].
    Ivanov II; Vdovenko VM; Bobrova VN; Gavrilenko IS; Rumiantseva LN
    Vopr Onkol; 1969; 15(9):50-5. PubMed ID: 5354749
    [No Abstract]   [Full Text] [Related]  

  • 3. [On the possibility of using 3-(3,4-dihydroxyphenyl)-alanine (DOPA) as a mediator of radioisotopes in a melanoma].
    Vdovenko VM; Ivanov II; Bobrova VN; Gavrilenko IS; Ivanov AI; Solov'ev AL; Rumiantseva LN
    Dokl Akad Nauk SSSR; 1965 Sep; 164(1):95-8. PubMed ID: 5872562
    [No Abstract]   [Full Text] [Related]  

  • 4. [Studies of the modification of central effects of 3,4-dioxyphenyl-alanine (DOPA) by alpha-methyl-dioxyphenylalanine (alpha-methyl-DOPA)].
    Matthies H; Fähse C; Lietz W
    Acta Biol Med Ger; 1967; 19(4):529-34. PubMed ID: 5596674
    [No Abstract]   [Full Text] [Related]  

  • 5. Radioactivity from labeled precursors of melanin in mice and hamsters with melanomas.
    Meier DA; Beierwaltes WH; Counsell R
    J Nucl Med; 1967 May; 8(5):391. PubMed ID: 6032718
    [No Abstract]   [Full Text] [Related]  

  • 6. THE INCORPORATION OF C14 FROM 3,4-DIHYDROXYPHENYLALANINE-2'-C14 INTO THE MELANIN OF MOUSE MELANOMAS.
    BLOIS MS; KALLMAN RF
    Cancer Res; 1964 Jun; 24():863-8. PubMed ID: 14190553
    [No Abstract]   [Full Text] [Related]  

  • 7. Radioactivity from labeled precursors of melanin in mice and hamsters with melanomas.
    Meier DA; Beierwaltes WH; Counsell RE
    Cancer Res; 1967 Aug; 27(8):1354-9. PubMed ID: 6047868
    [No Abstract]   [Full Text] [Related]  

  • 8. [Distribution of DL-3 (3,4-dihydroxyphenyl)-alanine-2 C14 in the organism of mice with Cloudmann's S91 melanoma].
    Delacretaz J; Emch M; Schellhorn JP
    Arch Belg Dermatol Syphiligr; 1970; 26(2):261-70. PubMed ID: 5515554
    [No Abstract]   [Full Text] [Related]  

  • 9. Effect of L-DOPA on transplanted malignant melanomas in mice.
    Robinson E; Wajsbort J; Mekori T
    Isr J Med Sci; 1973 Aug; 9(8):1062-3. PubMed ID: 4753849
    [No Abstract]   [Full Text] [Related]  

  • 10. [Distribution of pyrocatechol-3,4,5,6-3H4 and 3-(3,4-dihydroxyphenyl)-alanine-2,5,6-3H3 in tissues of mice with Garding-Passy melanoma after single and fractional injections].
    Vdovenko VM; Ivanov II; Bobrova VN; Rumiantseva LN; Volina VV
    Vopr Onkol; 1970; 16(7):67-74. PubMed ID: 5482844
    [No Abstract]   [Full Text] [Related]  

  • 11. DOPA DECARBOXYLASE ACTIVITY IN THE SKIN.
    MOELLER H
    Acta Derm Venereol; 1963; 43():485-90. PubMed ID: 14061560
    [No Abstract]   [Full Text] [Related]  

  • 12. Selective toxicity of 5-S-cysteinyldopa, a melanin precursor, to tumor cells in vitro and in vivo.
    Fujita K; Ito S; Inoue S; Yamamoto Y; Takeuchi J; Shamoto M; Nagatsu T
    Cancer Res; 1980 Jul; 40(7):2543-6. PubMed ID: 6771000
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Characterization of melanogenesis and morphogenesis of melanosomes by physicochemical properties of melanin and melanosomes in malignant melanoma.
    Jimbow K; Miyake Y; Homma K; Yasuda K; Izumi Y; Tsutsumi A; Ito S
    Cancer Res; 1984 Mar; 44(3):1128-34. PubMed ID: 6318981
    [TBL] [Abstract][Full Text] [Related]  

  • 14. [L-DOPA therapy of parkinsonism].
    Refsum S
    Nord Med; 1969 May; 81(18):570-1. PubMed ID: 5768311
    [No Abstract]   [Full Text] [Related]  

  • 15. On the use of ethanol as a scavenger in storing labelled dopa and 5-hydroxytryptamine in aqueous solutions.
    Waldeck B
    J Pharm Pharmacol; 1973 Jun; 25(6):502-3. PubMed ID: 4146596
    [No Abstract]   [Full Text] [Related]  

  • 16. Dopa oxidation and tyrosine oxygenation by human melanoma tyrosinase.
    Jergil B; Lindbladh C; Rorsman H; Rosengren E
    Acta Derm Venereol; 1983; 63(6):468-75. PubMed ID: 6198834
    [TBL] [Abstract][Full Text] [Related]  

  • 17. [Radiotherapy of malignant melanoma of the skin].
    Suter L; Fuhrmann D
    Praxis (Bern 1994); 2001 Mar; 90(10):397-402. PubMed ID: 11305185
    [TBL] [Abstract][Full Text] [Related]  

  • 18. [Electron microscopic studies of the effect of x-rays and L-3,4-dihydroxyphenylalanine (L-Dopa)--alone and in combination-- on Harding-Passey melanoma cells in monolayer cell culture].
    Proske H; Schachtschabel DO; Plamper G; Paul N; Pfab R
    Strahlenther Onkol; 1993 Aug; 169(8):500-7. PubMed ID: 8356510
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Radioimmunoconjugates for targeted alpha therapy of malignant melanoma.
    Abbas Rizvi SM; Sarkar S; Goozee G; Allen BJ
    Melanoma Res; 2000 Jun; 10(3):281-9. PubMed ID: 10890383
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Urinary 5-S-cysteinyldopa in Parkinsonism after DOPA and carbidopa.
    Stewart RM; Miller S; Gunder M
    Acta Derm Venereol; 1983; 63(2):97-101. PubMed ID: 6189350
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 179.